Clinical Trials Directory

Trials / Completed

CompletedNCT05645796

Improved Chest CT Diagnostic and Contrast Medium Administration

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
360 (actual)
Sponsor
Oslo Metropolitan University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

Investigation of impact of using different CM approaches on contrast enhancement in chest Ct examinations - A prospective study

Detailed description

Continuing advances in computed tomography (CT) in the past decades such as short scanning times with multi-detector CT (MDCT) requires contrast medium (CM) administration to be precisely planned to ensure a diagnostically accurate CT scans. To improve the chest CT diagnostic, the contrast enhancement in the thoracic vessels shoulde be increased. The most important patient-related factors affecting the magnitude of vascular and parenchymal contrast enhancement are body weight. Historical practice has been to use a fixed volume of CM independent of body weight. Research has shown a clear relationship between vessel enhancement and patient weight, and that fixed CM volume technique is inappropriate, as smaller patients may receive excessive volume, and larger patients insufficient volume resulting in reduced image quality and poor diagnostic. In addition, excess CM can result in contrast induced adverse effects and nephropathy. To overcome these problems, it is essential to adjust the CM volume to the patient's total body weight and body composition. This adjustment can be done in different ways. The aim of this study is to identify which weight/body tailored CM administration is the best replacement for fixed CM administration in chest CT. The cost and procedure time will also be explored.

Conditions

Interventions

TypeNameDescription
OTHERAdopted contrast media amount by using different approachesUsing different contrast media approaches recommended by literature to explore the impact on the contrast enhancement in chest CT

Timeline

Start date
2021-08-02
Primary completion
2023-01-15
Completion
2023-01-15
First posted
2022-12-12
Last updated
2023-03-29

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT05645796. Inclusion in this directory is not an endorsement.